Samina Khan, SVP, Chief Medical Officer at REATA PHARMACEUTICALS INC (RETA), sold 55,626 shares at $85.38 ($4.7M) on 2023-03-02, disclosed to the SEC on 2023-03-06.
Open-market sale of $4.7M RETA by SVP, Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $83.70 | 3,395 | $284K | 6.0% |
| 2 | $83.70 | 3,395 | $284K | 6.0% |
| 3 | $85.02 | 18,956 | $1.6M | 34.0% |
| 4 | $85.02 | 18,956 | $1.6M | 34.0% |
| 5 | $85.38 | 2,649 | $226K | 4.8% |
| 6 | $85.38 | 2,649 |
| $226K |
| 4.8% |
| 7 | $87.36 | 2,813 | $246K | 5.2% |
| 8 | $87.36 | 2,813 | $246K | 5.2% |
| Total | $85.13 avg | 55,626 | $4.7M | 100% |
| Filing → |